BMO Capital lowered the firm’s price target on Livent to $20 from $24 and keeps a Market Perform rating on the shares. The analyst cites the company’s Q3 earnings miss and reduced guidance primarily due to continued delays to the Argentine carbonate expansion and amid lower lithium prices and lower lithium multiples.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LTHM: